208 related articles for article (PubMed ID: 23184055)
1. Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency.
Ruseva MM; Vernon KA; Lesher AM; Schwaeble WJ; Ali YM; Botto M; Cook T; Song W; Stover CM; Pickering MC
J Am Soc Nephrol; 2013 Jan; 24(1):43-52. PubMed ID: 23184055
[TBL] [Abstract][Full Text] [Related]
2. Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis.
Lesher AM; Zhou L; Kimura Y; Sato S; Gullipalli D; Herbert AP; Barlow PN; Eberhardt HU; Skerka C; Zipfel PF; Hamano T; Miwa T; Tung KS; Song WC
J Am Soc Nephrol; 2013 Jan; 24(1):53-65. PubMed ID: 23204401
[TBL] [Abstract][Full Text] [Related]
3. Complement activity is regulated in C3 glomerulopathy by IgG-factor H fusion proteins with and without properdin targeting domains.
Gilmore AC; Zhang Y; Cook HT; Lavin DP; Katti S; Wang Y; Johnson KK; Kim S; Pickering MC
Kidney Int; 2021 Feb; 99(2):396-404. PubMed ID: 33129896
[TBL] [Abstract][Full Text] [Related]
4. C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy.
Williams AL; Gullipalli D; Ueda Y; Sato S; Zhou L; Miwa T; Tung KS; Song WC
Kidney Int; 2017 Jun; 91(6):1386-1397. PubMed ID: 28139294
[TBL] [Abstract][Full Text] [Related]
5. Complement receptor 3 mediates renal protection in experimental C3 glomerulopathy.
Barbour TD; Ling GS; Ruseva MM; Fossati-Jimack L; Cook HT; Botto M; Pickering MC
Kidney Int; 2016 Apr; 89(4):823-32. PubMed ID: 26924054
[TBL] [Abstract][Full Text] [Related]
6. Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.
Vernon KA; Ruseva MM; Cook HT; Botto M; Malik TH; Pickering MC
J Am Soc Nephrol; 2016 May; 27(5):1334-42. PubMed ID: 26374608
[TBL] [Abstract][Full Text] [Related]
7. Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice.
Fakhouri F; de Jorge EG; Brune F; Azam P; Cook HT; Pickering MC
Kidney Int; 2010 Aug; 78(3):279-86. PubMed ID: 20445496
[TBL] [Abstract][Full Text] [Related]
8. Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.
Boyer O; Noël LH; Balzamo E; Guest G; Biebuyck N; Charbit M; Salomon R; Frémeaux-Bacchi V; Niaudet P
Am J Kidney Dis; 2008 Apr; 51(4):671-7. PubMed ID: 18371543
[TBL] [Abstract][Full Text] [Related]
9. C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo.
Ruseva MM; Takahashi M; Fujita T; Pickering MC
Clin Exp Immunol; 2014 Apr; 176(1):84-92. PubMed ID: 24279761
[TBL] [Abstract][Full Text] [Related]
10. C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice.
Zhang Y; Keenan A; Dai DF; May KS; Anderson EE; Lindorfer MA; Henrich JB; Pitcher GR; Taylor RP; Smith RJ
JCI Insight; 2020 May; 5(9):. PubMed ID: 32376801
[TBL] [Abstract][Full Text] [Related]
11. Dense deposit disease and C3 glomerulopathy.
Barbour TD; Pickering MC; Terence Cook H
Semin Nephrol; 2013 Nov; 33(6):493-507. PubMed ID: 24161036
[TBL] [Abstract][Full Text] [Related]
12. Update on C3 glomerulopathy.
Barbour TD; Ruseva MM; Pickering MC
Nephrol Dial Transplant; 2016 May; 31(5):717-25. PubMed ID: 25326473
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.
Donadelli R; Pulieri P; Piras R; Iatropoulos P; Valoti E; Benigni A; Remuzzi G; Noris M
Front Immunol; 2018; 9():2329. PubMed ID: 30487789
[TBL] [Abstract][Full Text] [Related]
14. Unexpected role for properdin in complement C3 glomerulopathies.
Daha MR
J Am Soc Nephrol; 2013 Jan; 24(1):5-7. PubMed ID: 23243211
[No Abstract] [Full Text] [Related]
15. Liver factor B silencing to cure C3 glomerulopathy: Evidence from a mouse model of complement dysregulation.
Zanchi C; Locatelli M; Corna D; Cerullo D; Fishilevich E; Desai D; Rottoli D; Donadelli R; Noris M; Zoja C; Remuzzi G; Benigni A
Mol Immunol; 2023 Sep; 161():25-32. PubMed ID: 37481826
[TBL] [Abstract][Full Text] [Related]
16. Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice.
Pickering MC; Warren J; Rose KL; Carlucci F; Wang Y; Walport MJ; Cook HT; Botto M
Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9649-54. PubMed ID: 16769899
[TBL] [Abstract][Full Text] [Related]
17. Properdin binds independent of complement activation in an in vivo model of anti-glomerular basement membrane disease.
O'Flynn J; Kotimaa J; Faber-Krol R; Koekkoek K; Klar-Mohamad N; Koudijs A; Schwaeble WJ; Stover C; Daha MR; van Kooten C
Kidney Int; 2018 Dec; 94(6):1141-1150. PubMed ID: 30322716
[TBL] [Abstract][Full Text] [Related]
18. Mouse podocyte complement factor H: the functional analog to human complement receptor 1.
Alexander JJ; Wang Y; Chang A; Jacob A; Minto AW; Karmegam M; Haas M; Quigg RJ
J Am Soc Nephrol; 2007 Apr; 18(4):1157-66. PubMed ID: 17344423
[TBL] [Abstract][Full Text] [Related]
19. Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase.
Paixão-Cavalcante D; Hanson S; Botto M; Cook HT; Pickering MC
Mol Immunol; 2009 Jun; 46(10):1942-50. PubMed ID: 19411110
[TBL] [Abstract][Full Text] [Related]
20. Complement factor H deficiency accelerates development of lupus nephritis.
Bao L; Haas M; Quigg RJ
J Am Soc Nephrol; 2011 Feb; 22(2):285-95. PubMed ID: 21148254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
